Xiaojian Yao

4.4k total citations
95 papers, 3.6k citations indexed

About

Xiaojian Yao is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Xiaojian Yao has authored 95 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Virology, 64 papers in Infectious Diseases and 31 papers in Epidemiology. Recurrent topics in Xiaojian Yao's work include HIV Research and Treatment (65 papers), HIV/AIDS drug development and treatment (48 papers) and Immune Cell Function and Interaction (11 papers). Xiaojian Yao is often cited by papers focused on HIV Research and Treatment (65 papers), HIV/AIDS drug development and treatment (48 papers) and Immune Cell Function and Interaction (11 papers). Xiaojian Yao collaborates with scholars based in Canada, China and United States. Xiaojian Yao's co-authors include Éric A. Cohen, Zhujun Ao, Nicole Rougeau, Ramu A. Subbramanian, Mark A. Wainberg, Dominique Bergeron, J. Forget, Kallesh D. Jayappa, Andrew J. Mouland and Gary Kobinger and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Xiaojian Yao

95 papers receiving 3.5k citations

Peers

Countries citing papers authored by Xiaojian Yao

Since Specialization

Citations

This map shows the geographic impact of Xiaojian Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojian Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojian Yao more than expected).

Fields of papers citing papers by Xiaojian Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojian Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojian Yao. The network helps show where Xiaojian Yao may publish in the future.

Co-authorship network of co-authors of Xiaojian Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojian Yao. A scholar is included among the top collaborators of Xiaojian Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojian Yao. Xiaojian Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	UV-Inactivated rVSV-M2e-Based Influenza Vaccine Protected against the H1N1 Influenza Challenge 2024 ·Frontiers in Bioscience-Landmark ·(unknown), Zhujun Ao, Hiva Azizi, Maggie Jing Ouyang, (unknown), Lyle R. McKinnon, Darwyn Kobasa, Kevin M. Coombs, Gary Kobinger, Xiaojian Yao	2
2	Structure of Endophytes in the Root, Stem, and Leaf Tissues of Sweetpotato and Their Response to Sweetpotato Scab Disease Caused by Elsinoë batatas 2023 ·Agronomy ·Shixin Wang, Tingting Ma, Xiaojian Yao, Zhufang Yao, Zhangying Wang, Zhangyong Dong, Mei Luo, Lifei Huang	3
3	Protocol to evaluate the inflammatory response in human macrophages induced by SARS-CoV-2 spike-pseudotyped VLPs 2023 ·STAR Protocols ·Maggie Jing Ouyang, Zhujun Ao, (unknown), Xiaojian Yao	1
4	Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines 2022 ·Frontiers in Microbiology ·(unknown), Zhujun Ao, Hiva Azizi, (unknown), Kevin M. Coombs, Darwyn Kobasa, Gary Kobinger, Xiaojian Yao	6
5	Draft Genome Sequence of Diaporthe batatatis Causing Dry Rot Disease in Sweetpotato 2021 ·Plant Disease ·Yiling Yang, Xiaojian Yao, (unknown), (unknown), Jingyi Chen, Boping Fang, Lifei Huang	3
6	Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry 2021 ·PLoS ONE ·Zhujun Ao, Mable Chan, Maggie Jing Ouyang, (unknown), (unknown), Darwyn Kobasa, Xiaojian Yao	23
7	Type 2 familial hemophagocytic lymphohistiocytosis in half brothers 2018 ·Medicine ·Chunxia Liu, Ming Li, Xiaomei Wu, Xiaojian Yao, Li Zhao	9
8	Activation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412 2016 ·Virology Journal ·Zhujun Ao, Rong Zhu, Xiaoli Tan, Lisa Liu, Liyu Chen, Shuiping Liu, Xiaojian Yao	15
9	Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection 2016 ·Antiviral Research ·Xu Zhang, Zhujun Ao, Alexander Bello, (unknown), Shuiping Liu, Jeffrey T. Wigle, Gary Kobinger, Xiaojian Yao	40
10	R88-APOBEC3Gm Inhibits the Replication of Both Drug-resistant Strains of HIV-1 and Viruses Produced From Latently Infected Cells 2014 ·Molecular Therapy — Nucleic Acids ·Xiaoxia Wang, Zhujun Ao, Kallesh D. Jayappa, (unknown), Gary Kobinger, Xiaojian Yao	8
11	Characterization of Anti-HIV Activity Mediated by R88-APOBEC3G Mutant Fusion Proteins in CD4 ⁺ T cells, Peripheral Blood Mononuclear Cells, and Macrophages 2010 ·Human Gene Therapy ·Zhujun Ao, Xiaoxia Wang, Alexander Bello, Kallesh D. Jayappa, Zhe Yu, Keith R. Fowke, (unknown), (unknown), Junhua Li, Gary Kobinger, Xiaojian Yao	13
12	Characterization of the HIV-1 integrase chromatin- and LEDGF/p75-binding abilities by mutagenic analysis within the catalytic core domain of integrase 2010 ·Virology Journal ·Yingfeng Zheng, Zhujun Ao, Kallesh D. Jayappa, Xiaojian Yao	18
13	Design, Biologic Evaluation, and SAR of Novel Pseudo‐peptide Incorporating Benzheterocycles as HIV‐1 Protease Inhibitors 2010 ·Chemical Biology & Drug Design ·(unknown), Hang Zhang, Xiaojian Yao, (unknown), (unknown), Ming Yang	10
14	Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules 2008 ·Antiviral Research ·Zhujun Ao, Ami Patel, Kaylie N. Tran, (unknown), Keith R. Fowke, Kevin M. Coombs, Darwyn Kobasa, Gary Kobinger, Xiaojian Yao	21
15	Interaction of Human Immunodeficiency Virus Type 1 Integrase with Cellular Nuclear Import Receptor Importin 7 and Its Impact on Viral Replication 2007 ·Journal of Biological Chemistry ·Zhujun Ao, (unknown), (unknown), Zaikun Xu, (unknown), Alan Cochrane, Xiaojian Yao	91
16	Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import 2005 ·Retrovirology ·Zhujun Ao, Keith R. Fowke, Éric A. Cohen, Xiaojian Yao	46
17	Genetic Selection of Peptide Inhibitors of Human Immunodeficiency Virus Type 1 Vpr 2002 ·Journal of Biological Chemistry ·Xiaojian Yao, (unknown), Nicole Rougeau, (unknown), (unknown), Pierre Belhumeur, Éric A. Cohen	20
18	Structural and Functional Analysis of the Membrane-Spanning Domain of the Human Immunodeficiency Virus Type 1 Vpu Protein 1998 ·Virology ·(unknown), Jacques Friborg, Béatrice Allain, (unknown), Xiaojian Yao, Éric A. Cohen	55
19	Mutational analysis of the HIV-1 Vpu protein. 1994 ·PubMed ·Jacques Friborg, Xiaojian Yao, (unknown), S. Garzón, Éric A. Cohen	3
20	The effect of vpu on HIV-1-induced syncytia formation. 1993 ·PubMed ·Xiaojian Yao, S. Garzón, (unknown), William A. Haseltine, Éric A. Cohen	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact